1. Activist Investor Elliott's Arrival on the Doorstep of GSK May Require Boss Emma Walmsley to Strengthen the Defenses

    Activist Investor Elliott's Arrival on the Doorstep of GSK May Require Boss Emma Walmsley to Strengthen the Defenses

    The arrival of activist investor Elliott Management on the doorstep of Glaxosmithkline's glistening headquarters in Brentford has caught Emma Walmsley and her team on the hop. The pharmaceutical group is aware of investor disquiet about a lagging share price compared with peers on both sides of the Atlantic. The crossover in valuations between its main UK counterpart Astrazeneca and GSK, previously regarded as the UK's top rated big pharma group, has underlined perceived under-performance...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned